HomeHSCL › Filing
🔔 Get instant alerts when HSCL files quarterly results on BSE Start free trial →

Pursuant to Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....

Filed: 21 Sep 2026, 09:57 IST Exchange: BSE Category: Merger/Acquisition — Scheme of Arrangement
Board approved Scheme of Arrangement for demerger of Tyre Business from Dalmia Bharat Refractories to Himadri Speciality Chemical - Demerger effective from 1 Oct 2026, subject to approvals including NCLT, SEBI, stock exchanges - Tyre Business turnover INR 149.31 Cr (3.39% of Himadri's turnover FY26) - Scheme aims to strengthen integration, operational synergies, and growth in tyre value chain - Share Entitlement Ratio: 1 Himadri share for every 260 Dalmia Bharat shares - Resulting Company shares to be listed on BSE and NSE post approvals
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 HSCL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add HSCL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Himadri Speciality Chemical Limited

Important. The summary above is generated automatically from Himadri Speciality Chemical Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.